Literature DB >> 10913388

Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses.

L A Jackson1, J D Cherry, S P Wang, J T Grayston.   

Abstract

Banked acute-phase and convalescent-phase serum samples from a previous study of respiratory illness in university students were examined for significant (>/=2-fold) increases in ELISA titers of IgA and IgG antibody to Bordetella pertussis filamentous hemagglutinin, pertactin, and fimbriae-2 and >/=4-fold titer increases to agglutinogens by agglutination. ELISA titers of antibody to pertussis toxin could not be determined because of technical problems. Chlamydia pneumoniae infections were diagnosed by culture or by a >/=4-fold increase in immunofluorescence assay titer or a single high titer (>/=512). Mycoplasma pneumoniae, influenza A and B, adenovirus, and respiratory syncytial virus infections were diagnosed by >/=4-fold increases in complement fixation titer or a single high titer (>/=64). There were 319 subjects with cough of >/=5 days' duration, and of these, 47 (15%) had significant increases in antibody to B. pertussis antigens; 26 (8%) had significant increases to fimbriae-2 or agglutinogens, indicative of B. pertussis infection, and 2 (1%) had evidence of non-B. pertussis bordetella infections. Seventeen (36%) had evidence of mixed infections or cross-reacting antibodies (influenza B infections, 5; adenovirus infections, 4; influenza A infections, 3; C. pneumoniae infections, 3; and M. pneumoniae infections, 2). Our findings suggest that bordetella infections are common in young adults with cough illnesses (incidence, 9%), and a surprising number of these are mixed infections with other respiratory pathogens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913388     DOI: 10.1086/313911

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases.

Authors:  Boulos Maraha; Martin den Heijer; Jan Kluytmans; Marcel Peeters
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

3.  Brief Report: Seroprevalence of Pertussis Infection in HIV-Infected Adults in the United States.

Authors:  Stephanie B Troy; Alexandria E-B Rossheim; DaShaunda D Hilliard; Tina D Cunningham
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

4.  Dual infection with Bordetella pertussis and Mycoplasma pneumoniae in three infants: case reports.

Authors:  A Zouari; A Touati; H Smaoui; D Brun; K Kasdaghli; K Menif; N Ben Jaballah; E Ben Hassen; N Guiso; A Kechrid
Journal:  Infection       Date:  2011-08-23       Impact factor: 3.553

Review 5.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Suppression of NF-kappaB-mediated beta-defensin gene expression in the mammalian airway by the Bordetella type III secretion system.

Authors:  Diana Legarda; Marcia E Klein-Patel; Sunghan Yim; Ming H Yuk; Gill Diamond
Journal:  Cell Microbiol       Date:  2005-04       Impact factor: 3.715

7.  Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay.

Authors:  Meryta L May; Suhail A Doi; David King; Jenny Evans; Jennifer M Robson
Journal:  Clin Vaccine Immunol       Date:  2011-11-30

8.  Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness.

Authors:  Elektra Szewczuk; Kiran Thapa; Terry Anninos; Kenneth McPhie; Geoff Higgins; Dominic E Dwyer; Keith K Stanley; Jonathan R Iredell
Journal:  BMC Infect Dis       Date:  2010-05-11       Impact factor: 3.090

9.  Respiratory tract infections during the 2011 Mycoplasma pneumoniae epidemic.

Authors:  N Reinton; L Manley; T Tjade; A Moghaddam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-25       Impact factor: 3.267

10.  Pertussis antibodies in postpartum women and their newborns.

Authors:  J H Shakib; S Ralston; H H Raissy; G J Stoddard; K M Edwards; C L Byington
Journal:  J Perinatol       Date:  2009-10-08       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.